EFMH
MIRM icon

E Fund Management (HK)’s Mirum Pharmaceuticals MIRM Stock Holding History

E Fund Management (HK)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7K Buy
245
+78
+47% +$7.83K 0.01% 245
2026
Q1 		$15.4K Buy
+167
New +$15.7K 0.01% 242

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

E Fund Management (HK)'s MIRM Position: Q2 2026 in Review

E Fund Management (HK) increased its Mirum Pharmaceuticals (MIRM) stake by 47% in Q2 2026, buying an estimated $7.83K and bringing the position to 245 shares worth $28.7K. The position accounts for 0.01% of the portfolio, ranked #245.

E Fund Management (HK) first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • E Fund Management (HK) held 245 shares of Mirum Pharmaceuticals worth $28.7K as of Q2 2026.
  • E Fund Management (HK) bought 78 Mirum Pharmaceuticals shares in Q2 2026, an estimated $7.83K.
  • Mirum Pharmaceuticals made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #245 holding.
  • E Fund Management (HK) first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.